NASDAQ
CASI Pharmaceuticals, Inc. (CASI) has a fcf yield of -67.87% as of Friday, May 29, 2026. This represents a 46.53% decrease compared to its 12-month average of -46.32%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.